Globomedica AG

What Globomedica AG does

Globomedica AG is a Swiss pharmaceutical micro-logistics and specialty pharmacy operator headquartered in Egg, Switzerland. The company runs two core lines under a single corporate entity: PHARMACARE, a B2B pre-wholesale distribution service providing modular outsourcing solutions to partner pharmaceutical companies and delivering to hospitals, doctors, pharmacies and sales-force employees nationwide; and APOTHEKE, a specialty pharmacy offering direct-to-patient shipment of medications in specific therapeutic areas (notably Rebif for Multiple Sclerosis) with direct billing to Swiss health insurers and no surcharges for shipping or taxes. Operations are built on a GDP-compliant quality management system supported by GMP certification and the full stack of Swissmedic operating licences (wholesale, narcotics, distance selling, retail medicines).

The company traces its origin to a community pharmacy founded in the 1960s. It was acquired by Globopharm AG in 1993, which seeded partnerships with major manufacturers including Novartis Pharma Schweiz AG, Genzyme GmbH (now Sanofi) and Gilead Sciences Switzerland Sàrl. A 2009 management buyout returned the business to proprietor-managed family ownership, and in February 2016 Globomedica merged with Mediq Suisse AG to become part of the international Mediq Group, combining the two entities' Swiss pharmaceutical services capabilities under a single umbrella.

The business model is service-based and quote-driven: revenues come from managed distribution and logistics service fees on the B2B side and medication dispensing plus insurance-billing administration on the B2C specialty pharmacy side. Pricing is not publicly disclosed and is described as individualised and offered at favourable conditions. Go-to-market is sales-led with key-account treatment of every customer, supported by a multilingual (DE/FR/IT/EN) corporate website, direct contact channels and a single physical site in Egg. The company employs approximately 7 people and operates exclusively in Switzerland, with no disclosed proprietary technology platform, no AI/ML capabilities, and no third-party technology integrations beyond partner listings (exaSys, Yaveon).

Name

Globomedica AG

Legal name

Globomedica AG

Website

https://globomedica.ch

Company type

Private

Founded year

1960

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution Services

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Pharmacies and Drug Retailers (45611)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Retail-Drug Stores And Proprietary Stores (5912)

akta.pro primary industry

Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)

akta.pro secondary industry

Prescription Pharmaceutical (Rx) Wholesale Distribution (CRAOAHAA)

Keywords

• Pharmaceutical distribution
• Specialty pharmacy
• Pharma micro-logistics
• Pre-wholesale logistics
• Pharmaceutical compliance

Headquarters

HQ city

Egg

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Pharmaceutical Distribution Services (Pharmacare): Full-service pre-wholesale logistics and distribution solutions for pharmaceutical products. Services are provided to partner companies along the distribution chain to end customers (hospitals, doctors, pharmacies, sales force employees). Revenue generated through service fees for distribution, warehousing, and logistics management.
2. Specialty Pharmacy Direct Shipment: Direct shipment of medications for special therapeutic areas to patients in Switzerland. Services include direct billing to health insurance companies. Revenue generated through medication dispensing fees and administrative services.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels1 record

Core offering

Globomedica AG operates as a Swiss pharmaceutical micro-logistics and specialty pharmacy provider. Through its PHARMACARE service, it delivers individualized pre-wholesale distribution solutions for partner pharmaceutical companies to end customers (hospitals, doctors, pharmacies, sales force employees). Through its APOTHEKE specialty pharmacy, it provides direct shipment of medications for special therapeutic areas (e.g., Rebif therapy for Multiple Sclerosis) to patients throughout Switzerland, with direct billing to health insurers at favorable conditions.

Product overview

Globomedica AG operates a dual-product portfolio consisting of PHARMACARE and APOTHEKE (Specialty Pharmacy). PHARMACARE is the pharmaceutical micro-logistics and distribution division providing individualized pre-wholesale solutions and serving as an important link in the distribution chains of partner pharmaceutical companies (including Novartis, Genzyme, Gilead Sciences). The APOTHEKE division is the specialty pharmacy offering direct shipment of medications for special therapeutic areas (such as Rebif therapy for Multiple Sclerosis) to patients throughout Switzerland, with direct billing to health insurers at favorable conditions. Both divisions share operational synergies under the same corporate entity, with a combined focus on flexibility, quality, and customer-centric pharmaceutical services across Switzerland.

Differentiator

Problem solved

Functional benefit

Products and services

• PHARMACARE A pharmaceutical micro-logistics and distribution service that delivers complete, individualised pre-wholesale solutions tailored to partner pharmaceutical companies' needs, functioning as a full-service provider in the distribution chain to end customers (hospitals, doctors, pharmacies, sales force employees).
• APOTHEKE (Specialty Pharmacy) A specialty pharmacy service offering direct shipment of medications for special therapeutic areas (such as Rebif therapy for Multiple Sclerosis) to patients throughout Switzerland at favorable conditions, with billing directly to health insurers, no surcharge for shipping or fees, and a hotline for orders and application questions.

Quantifiable outcome

• No supplementary charges for taxes or shipping costs for specialty pharmacy services
• +1 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Six partnerships are on record, tiered core and minor.

• Mediq Suisse AGcoreStrategic or Co-development Partner · 1 February 2016In February 2016, Globomedica merged with Mediq Suisse AG to extend services and offer a comprehensive portfolio of products and services. Globomedica AG is now part of the international Mediq Group. This merger represents a significant strategic integration combining both companies' capabilities in the Swiss pharmaceutical market.
• Novartis Pharma Schweiz AGminorStrategic or Co-development PartnerPartnership established after 1993 acquisition by Globopharm AG. Novartis is one of several pharmaceutical company partnerships that Globomedica developed to expand its distribution business. Nature of partnership involves pharmaceutical distribution services.
• Genzyme GmbHminorStrategic or Co-development PartnerPartnership formed as part of Globomedica's expansion of distribution services after 1993. Genzyme (now part of Sanofi) is a biotechnology company. Partnership involves distribution of specialty pharmaceutical products.
• Gilead Sciences Switzerland SàrlminorStrategic or Co-development PartnerPartnership established for pharmaceutical product distribution. Gilead Sciences is a biopharmaceutical company. Partnership supports Globomedica's distribution business segment.
• Globopharm AGminorStrategic or Co-development PartnerAcquired Globomedica in 1993 enabling expansion from core pharmacy business to larger distribution tasks. Underwent management buyout in 2009, making Globomedica independent until 2016 merger with Mediq Suisse AG.
• Mediq SuissecoreStrategic or Co-development PartnerListed as 'sister company' on Globomedica's links page. Both companies are part of the international Mediq Group following the 2016 merger, representing the combined Swiss operations of Mediq.

Scale indicators3 records

Recent moves9 records

Expansion highlights4 records

Broad incumbents

• Cardinal Health: US-headquartered global healthcare services and pharmaceutical distribution company. Operates a broad portfolio including pharma distribution, specialty pharmacy, and at-Home solutions - conceptually adjacent to Globomedica's dual B2B/B2C model but at significantly larger scale.
• Phoenix Group AG: Pan-European pharmaceutical distribution giant operating across 29 countries and parent of Galexis and Alliance Healthcare Switzerland. A broad incumbent with overlapping pharma distribution capabilities, but operating at continental scale rather than Globomedica's micro-logistics niche.
• McKesson Corporation: Global pharmaceutical distributor and healthcare services company operating in North America and Europe. Overlaps with Globomedica's pharma distribution and specialty services capabilities but at enterprise scale across many product categories and geographies.
• Cencora Inc. Global pharmaceutical distribution and specialty services provider (formerly AmerisourceBergen). Comparable as a broad incumbent operating pharmaceutical distribution and specialty pharma services worldwide, though at vastly larger scale than Globomedica.

Regional players

• Voigt Industrie Service AG: Swiss pharmaceutical logistics and distribution company offering GDP-compliant warehousing and distribution services for healthcare manufacturers. Comparable as a regional pharma logistics specialist, though positioned more as a contract logistics partner than a specialty distributor.

Direct peers

• DocMorris NV: Swiss-headquartered online pharmacy and mail-order pharmacy operator (formerly Zur Rose). Directly comparable to Globomedica's APOTHEKE specialty pharmacy division in delivering medications directly to patients across Switzerland with insurance billing capabilities.
• Galexis AG: Switzerland's largest pharmaceutical wholesaler and logistics provider, subsidiary of Phoenix Group. Directly comparable as a Swiss pharma distribution services competitor offering wholesale, GDP-compliant logistics, and national reach to pharmacies and hospitals - the same core services Globomedica's PHARMACARE division provides.
• Streuli Pharma AG: Swiss pharmaceutical distribution and logistics company supplying pharmacies and healthcare providers across Switzerland. Comparable in operating a domestic pharma distribution services business serving Swiss healthcare customers under GDP-compliant conditions.
• Alliance Healthcare Switzerland: Swiss pharmaceutical distribution and wholesaling business also owned by Phoenix Group. Directly competes with Globomedica in supplying pharmacies, hospitals, and doctors across Switzerland, including specialty pharma handling under GDP guidelines.

Others

• DHL Supply Chain (Life Sciences & Healthcare): Global logistics provider with dedicated Life Sciences & Healthcare division offering GDP-compliant pharma warehousing, distribution, and cold-chain capabilities. Comparable as an adjacent logistics provider rather than direct competitor, given DHL's much broader multi-industry footprint.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/globomedica-ag

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Globomedica AG